Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 60/100

BD to Present at Investor Healthcare Conferences BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following...

Key Takeaway: Becton, Dickinson and Company (BDX) has announced its participation in upcoming healthcare conferences, including Citi's Unplugged Medtech and Life Sciences Access Day and the Barclays Global Healthcare Conference. These events aim to foster investor relations and showcase the company's advancements in medical technology. BD emphasizes its commitment to improving healthcare outcomes through innovation and collaboration.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is participating in prominent healthcare conferences, highlighting its commitment to engage with investors.
  • The company is recognized as a leading global medical technology firm with a significant impact on health care.
  • BD's innovative technology and solutions aim to enhance clinical therapy and care delivery.

Full Press Release Details

FRANKLIN LAKES, N.J. , Feb. 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the following healthcare conferences:
Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 29, 2024 8:00 am Eastern Time
Barclays 26 th Annual Global Healthcare Conference March 13, 2024 9:30 am Eastern Time
The live webcasts of BD's presentations can be accessed from the BD investor relations website, investors.bd.com . A replay of the events will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

What conferences will BD present at in 2024?

BD will present at Citi's 2024 Medtech Day on February 29 and Barclays on March 13.

How can I access BD's presentation webcasts?

Live webcasts of BD's presentations can be accessed on their investor relations website.

What is BD's role in healthcare?

BD advances health through innovative technologies, improving diagnostics and care delivery.

How many employees does BD have?

BD employs over 70,000 individuals worldwide in the medical technology field.

Where can I find more information about BD?

More information about BD can be found on their website bd.com or LinkedIn.

Last updated: Feb 15, 2024